the safety and efficacy of avapritinib in patients with advanced systemic mastocytosis
Published 1 year ago • 226 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
2:56
insights into the treatment and management of advanced systemic mastocytosis
-
1:51
responses to avapritinib in patients with advanced systemic mastocytosis
-
3:54
summit study: safety & efficacy of bezuclastinib in patients with nonadvanced systemic mastocytosis
-
9:29
pioneer: avapritinib in patients with indolent systemic mastocytosis
-
5:21
systemic mastocytosis: current treatments and emerging targeted agents
-
1:46
updated analyses from the pathfinder trial: avapritinib therapy in advanced systemic mastocytosis
-
4:46
management strategies for advanced systemic mastocytosis
-
1:27
ongoing trials and novel agents being explored in advanced and indolent systemic mastocytosis
-
47:33
chapter 46 alteration in cellular regulation hematological or neoplastic disorders
-
24:20
introduction to haemostasis
-
37:09
yale20 - hematology emergencies
-
3:05
explorer: avapritinib in systemic mastocytosis
-
2:21
avapritinib updates in advanced systemic mastocytosis: explorer and pioneer
-
1:46
unmet needs and challenges in advanced systemic mastocytosis
-
2:07
avapritinib for indolent systemic mastocytosis
-
1:00
complete remission seen in advanced systemic mastocytosis with avaritinib
-
2:37
current approaches to treating systemic mastocytosis
-
2:20
avapritinib fda approval for advanced systemic mastocytosis
-
1:50
unmet needs and challenges in mastocytosis
-
0:52
the unmet needs that remain for patients with systemic mastocytosis
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis